HIV and its effects on bone: a primer for rheumatologists

Area of Science:

• Bone Metabolism and HIV
• Rheumatology and Infectious Diseases

Background:

• Effective HIV treatments lead to longer lifespans, increasing comorbidities like bone complications.
• Osteopenia and osteoporosis are more prevalent in the HIV population.
• Fracture risk and avascular necrosis (AVN) in HIV patients require further investigation.

Purpose of the Study:

• To review the current literature on bone complications in the HIV population.
• To explore the relationship between antiretroviral therapy (ART) and bone health.
• To identify gaps in knowledge regarding fracture risk and AVN in HIV patients.

Main Methods:

• Literature review of recent studies on HIV, bone mineral density, and fractures.
• Analysis of data on the effects of specific ART regimens on bone health.
• Examination of evidence for vitamin D and calcium supplementation in HIV-associated bone loss.

Main Results:

• HIV patients exhibit increased rates of osteopenia and osteoporosis.
• The interplay of traditional, HIV-specific, and ART-related factors contributes to bone loss.
• Conflicting data exist regarding ART's impact on fracture risk and the efficacy of supplementation.

Conclusions:

• Bone disease is a significant and growing concern in the HIV population.
• The precise role of ART in bone complications like fracture and AVN remains unclear.
• Further research is essential to develop effective prevention and management strategies for bone disease in HIV.